Remove 2023 Remove Clinical Pharmacology Remove Organic Chemistry Remove Pharmaceuticals
article thumbnail

Antibody Drug Conjugates: windows of opportunity

Drug Target Review

Author bios: Dr Petra Dieterich Petra has 30 years’ experience of drug development in the Pharmaceutical industry with a focus on supporting CMC activities. Working in the CRO and CDMO environment she has led projects for customers across the globe, helping them to achieve their goals in clinical trials and low volume commercial manufacture.

article thumbnail

What to expect from PEGS Europe 2023: Day 1

Drug Discovery World

On Day 1, Tuesday 14 November 2023, the tracks include: Display of biologics, antibody-based cancer therapies, safety and efficacy of bispecific antibodies, modulating the tumour microenvironment, optimisation and developability, and cell line and systems engineering. from engineered peptide and antibody libraries’.